X4 Pharmaceuticals, Inc. (XFOR) KPIs & Operating Metrics

Name: XFOR (X4 Pharmaceuticals, Inc.) KPIs and Operating Metrics
Creator: Signals.AI

X4 Pharmaceuticals, Inc. (XFOR) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.

KPIs — source: SEC EDGAR, earnings calls, investor decks
Metric	Latest Value	Period
Net Zolremdi Product Revenue	1.6M	FY2025-Q3
Phase 3 4WARD Trial Target Enrollment	176.00	FY2025-Q3
Cost of ZorMD Revenue	300K	FY2024-Q4

Back to XFOR overview · XFOR earnings · XFOR holders

Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.